Clinical Trial Update: Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

View source ↗

Summary

This clinical trial update reports on the durability of seroconversion in chronic hepatitis B patients who previously seroconverted in a Gilead-sponsored study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Status: COMPLETED